FILING ANALYSIS · MONDAY, NOVEMBER 16

VYCOR MEDICAL INC VYCO — 8-K: Results of Operations and Financial Condition

negative

Vycor Medical reported a 19% decrease in revenue for the three months ended September 30, 2026, and an 11% decrease in revenue for the nine months ended September 30, 2026, with operating profit also decreasing, indicating a negative impact on the stock price. The company's non-GAAP operating profit also decreased, and the revenue decrease was largely due to lower US sales, which could lead to inv

The filing

8-K - VYCOR MEDICAL INC (0001424768) (Filer)

Read the filing on SEC EDGAR →

How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.

Get filings like this every market day

The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.

Subscribe free →
All analyses · Earnings today · Latest brief · Track record
© 2026 Dutchcode B.V. · Built by
Blinkof.ai verified — grade A+